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Abstract. To better delineate the impact of parasitic coinfection in coastal Kenya, we developed a novel specimen-
sparing bead assay using multiplex flow immunoassay (MFI) technology to simultaneously measure serum or plasma
immunoglobulin G4 (IgG4) against Brugia malayi antigen (BMA) and Schistosoma haematobium soluble worm antigen
(SWAP). Properties of the bead assay were estimated by latent class analysis using data from S. haematobium egg counts/
filarial rapid diagnostic cards (RDTs), parasite-specific enzyme-linked immunosorbent assays (ELISAs), and the
multichannel IgG4 assay. For schistosomiasis, the bead assay had an estimated sensitivity of 81% and a specificity of
45%, and it was more sensitive than ELISA or urine egg counts for diagnosing infection. For filariasis, it had a sensitivity
of 86% and a specificity of 39%, and it was more sensitive than ELISA or RDT. Measuring antibody by MFI is feasible
and may provide more accurate epidemiological information than current parasitological tests, especially in the setting of
low-intensity infections.
INTRODUCTION
The impact of parasitic infections on the health of low-
income countries has been regularly underestimated. This
underestimation is, at least in part, because of a lack of fully
sensitive diagnostic testing for helminth infections, particularly
when infections are of low intensity.1 Misclassification bias
caused by inaccurate gold standard laboratory diagnostics has
resulted in an underappreciation of the effects of chronic hel-
minth infections in early childhood, especially in terms of such
subtle morbidities as growth retardation, wasting, and anemia.
New interest has developed in the disabling effects of multiple
concurrent parasitic infections—polyparasitism—including the
possible deleterious interaction of mixed protozoan and hel-
minthic infections on human development.2–6
On the Kenyan coast, coinfection by parasites is common,
where up to 55% of rural survey participants have had two or
more concurrent parasite infections detected.7 This finding
has been confirmed in other endemic regions,2–5,7 and in some
settings, the detrimental effects of combined parasite infec-
tions have been shown to be synergistic as opposed to merely
additive.6,8,9 The study of the health complications of concur-
rent parasitic infections calls for tools that are able to accu-
rately characterize infection status while efficiently screening
for multiple parasites. In areas of low prevalence, sensitive
serological testing can help increase the efficiency of detec-
tion for these infections, because traditional methods, such as
egg counting for schistosomiasis, often miss infections when
helminth intensity is low.10,11 Improved testing can, therefore,
allow for more accurate patterning of infection prevalence,
which can then be used in the development of more effective
control programs.10
Multiplex flow immunoassay (MFI) technology is a rela-
tively recent innovation that has been used for polymerase
chain reaction (PCR) readouts, serological testing, cytokine
detection, and other biological assays.12 MFI uses a liquid
suspension array of unique microspheres (5–6 mm in diameter)
that are conjugated to different capture molecules. These
beads are internally labeled with a fluorescent dye and confer
a unique fluorescence when a secondary reporter molecule
binds to the antigen–bead combination. In serological testing
for antiparasite antibodies, a mixture of differently colored
beads (each bead conjugated to a different parasite antigen) is
combined with a minimal aliquot of patient serum followed
by the addition of a fluorescently labeled (phycoerythrin
[PE]) reporter secondary antibody. Specific antibody binding
response to each test antigen is then detected (according to
bead color) and quantified in a flow-based detector.12 The plat-
form has been used successfully for detection of viral infections
(such as Epstein Barr virus [EBV] and herpes simplex virus
[HSV]), bacterial infections, and malaria.13–18 There has been
limited experience with helminth infections, although MFI
technology has been used in a study on the risk of reinfection
of Schistosoma japonicum.19 Most importantly, in these studies,
the MFIs have been shown to be comparable with more tradi-
tional immunoassays in detecting antibodies to various infec-
tions.13,14,17,18 Although the technology remains complex and
not readily available for field use in diagnosing infection, it
could be very useful in research and epidemiologic surveys,
given the ability to test for many infections simultaneously.
During parasitic infections or allergic conditions, immuno-
globulin G4 (IgG4) can account for more than 50% of IgG,
making it a good candidate target for a multiplex helminthic
infection diagnostic platform.20,21 Furthermore, studies of
human isotypic antibody responses to S. haematobium and
Wuchereria bancrofti infections have shown that IgG4 levels
are quite sensitive and specific for detecting current or very
recent infections.22–24
Immune responses to Schistosoma species are well-known
to vary by age, although evidence shows that these result
may be more from cumulative exposure in older individuals
than strict age variations in immune response.25 IgG4 to
Schistosoma antigens has been shown to drop in the weeks to
months after treatment, making it a good candidate to dif-
ferentiate active infection from a prior treated infection.26–28
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For lymphatic filariasis (LF), antibody responses occur
before antigenemia and thus, prove to be useful for detecting
early infection.29 Furthermore, IgG4 to LF parasites has
been shown to be elevated in active infections and decline
after treatment.21,30–32
The present paper describes the development and prelimi-
nary testing of a multichannel fluorescent IgG4 antibody
detection assay for the study of LF and urogenital schistoso-
miasis among resident populations in Coast Province, Kenya.
METHODS
Study population. Individuals from the three villages of
Mililani, Nganja, and Vuga in Kwale County, Coast Province,
Kenya were surveyed as part of a population-based, longitu-
dinal research project.33 Subjects were eligible if they were
over 5 years old, local residents for more than 2 years, and
able to provide urine, stool, and blood specimens. Overall,
2,501 participants were enrolled in the three villages. Blood
(1 mL) was collected by finger prick or heel stick, with small
aliquots taken for hemoglobin determination and rapid card
testing for filaria antigen (Binax, Portland, ME). Plasma was
separated, stored in labeled Eppendorf tubes, and kept at
−80°C until processed. Urine and stool were collected by
participants and brought for evaluation by standard egg
detection parasitological testing on site.34–36 Presence of
S. haematobium infection was screened for by Nuclepore filtra-
tion of two 5-mL aliquots of a single midday urine specimen.
Demographic data collected in the field were entered in hand-
held devices (Dell Axim, Round Rock, TX) using Visual CE 10
(Cambridge, MA). Data were then transferred into ACCESS
2007 (Microsoft, Seattle, WA). Parasitology and anthropo-
metric data were then entered to complete the database.
Target antigen selection for novel assay. Seroresponse with
IgG4 to Brugia malayi antigen (BMA) was used as the marker
for filarial infection, because this antigen is preserved across
species and can be used to detect exposure to W. bancrofti,
the filarial worm endemic to Kenya.37,38 The antigen prepara-
tion to detect S. haematobium infection was soluble adult
worm antigen (SWAP), which has been used frequently in
diagnostic enzyme-linked immunosorbent assays (ELISAs)
and can be readily prepared.39 In past studies, sensitivity for
diagnosing Schistosoma infection using SWAP (by ELISA for
total IgG) has been shown to be comparable with sensitivity
using soluble egg antigens.39,40
Multichanneled fluorescent antibody detection assay.
SWAP antigen (crude extract) was provided courtesy of the
laboratory of Christopher King (Center for Global Health
and Diseases, Case Western Reserve University, Cleveland,
OH). The crude extract for BMA was prepared as described
below, with male and female worms obtained through the
Filariasis Research Reagent Resource Center (http://www
.filariasiscenter.org/).
BMA extract was prepared from live adult B. malayi worms
(30 females and 30 males). They were washed five times in
1 + phosphate-buffered saline (PBS). The wash buffer was
removed, and the worms were transferred to autoclaved glass
mortars, where they were manually homogenized on ice until
there was no intact tissue visible and the homogenate was
milky in appearance. The preparation was then sonicated on
an ice bath for 10 minutes and left overnight at 4°C on a rotor.
After centrifuging the mixture at 3,000 rpm for 20 minutes,
the supernatant was removed and transferred to microfuge
tubes. This solution was then centrifuged for 30 minutes at
14,000 rpm at 4°C, and the supernatant was removed.
IgG4 antibody responses to SWAP and BMA were assessed
using a high-throughput bead-based platform (Bioplex; Bio-
rad, Hercules, CA), allowing the simultaneous detection of
the panel of antigens with a single serum sample; 50 mg SWAP
or 1 mg BMA was covalently coupled to differently colored
beads (bead 52 for SWAP and bead 53 for BMA), with each
bead having a unique dye that allowed for automated discrim-
ination of fluorescence values in the multiplex assay using
6.125 + 105 beads per sample. Pooled plasma samples from
areas endemic for schistosomiasis, filariasis, and hookworm
were initially used to optimize the working dilutions of
sample and secondary antibodies in the assay. Sera from non-
exposed North American donors were used as negative con-
trols in the development of the assay. The above protein
content of each antigen coupled to the beads was chosen as
the lowest concentration that produced the maximal fluores-
cence with positive sera. Furthermore, because the use of
crude antigen extracts could predispose beads to aggregate,
the lowest effective antigen–bead concentrations were neces-
sary to minimize any aggregation that would interfere with
accurate measurement of the fluorescence. Beads were lyoph-
ilized for storage after conjugation.
In the standardized assay, patient sera and control sera
were diluted in the assay buffer of PBS with 1% bovine serum
albumin (BSA) plus 0.05% Tween 20 (PBT) at 1:50 and
incubated with beads for 30 minutes while shaking at
room temperature. Plates were then washed two times with
100 mL assay buffer followed by incubating with 100 mL 1:100
R-phycoerythrin (RPE) -conjugated anti-human IgG4 (South-
ern Biotech) for 30 minutes at room temperature with shaking.
Beads were then washed two times with 100 mL assay buffer,
resuspended in 100 mL assay buffer, and passed through the
Bioplex analyzer to detect specific antibody binding. Individ-
ual beads were counted and scored for type (by fluorescence
color) and PE fluorescence. The number and intensity of PE-
positive beads for each color bead were used to determine the
presence or absence of antigen-specific IgG4 in the patient
sample. Cutoff values for all of the samples were set at 2 SDs
above the mean fluorescent reading of 20 samples run with
control sera from an area endemic for multiple species of
parasites but not endemic for schistosomiasis or filariasis
(courtesy of Christopher King Laboratory). This process min-
imized potential false positivity of the assay from any low-
level cross-reactivity to non-study parasites.
Protocols for comparator anti-SWAP and anti-BMA
ELISAs. A subset of 111 subjects was tested by ELISA.
They were chosen from all three villages in group-wise fash-
ion from three strata that had low, medium, and high fluo-
rescence on the multiplex assay to evaluate all levels of
fluorescence; 96-well plates were coated with 50 mL 10 mg/mL
SWAP or BMA diluted in ELISA coating buffer and allowed
to incubate at 4°C overnight. The plates were then blocked
with ELISA blocking buffer and washed with ELISA wash
buffer as described previously.41,42 Serum samples prepared
in ELISA diluent buffer at a dilution of 1:50 were then
allowed to incubate on the antigen-coated plate at 4°C over-
night.41 The plates were washed six times and incubated with
50 mL 1:2,000 dilution mouse anti-human IgG4 (Jackson
ImmunoResearch, West Grove, PA) for 2 hours. The plates
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were washed and incubated with 50 mL 1:1,000 dilution
goat anti-mouse alkaline phosphatase-conjugated antibody
(Jackson ImmunoResearch, West Grove, PA) for 1 hour.
The plates were washed and incubated with alkaline phospha-
tase substrate in buffer (Sigma Aldrich, St. Louis, MO) for
15 minutes. After 15 minutes, the reaction was stopped with
50 mL 5% (ethylenedinitrilo)tetraacetic acid (EDTA). Bound
IgG4 was then measured by determination of optical density
at 415 nm. Like the multiplex assay, the cutoff for positivity
was set at 2 SDs above the mean optical density of 20 negative
controls from an area in northern Kenya, an area endemic for
multiple species of parasites but not endemic for schistosomi-
asis or filariasis (courtesy of Christopher King Laboratory).
This cutoff value was set at the outset and not repeated
with each plate.
Statistical analysis. Initial statistical analysis was performed
with SPSS (v.20; IBM Corp, Armonk, NY.), including linear
correlation of bead assay results with the respective ELISA
tests. Because of the known insensitivity of standard parasito-
logical testing, the sensitivity and specificity of the multiplex
assay for parasite diagnosis were estimated using latent class
analysis based on the data from all completed tests with the
use of Bayes Latent Class Models software (BLCM soft-
ware43; available at http://www.med.mcgill.ca/epidemiology/
Joseph/Bayesian-Software-Diagnostic-Testing.html). In the
modeling of S. haematobium infection, the a priori specificity
of egg detection was set high (at 95–99%) based on very low
expected false positivity rates for this test. For other esti-
mates, including all of the filarial testing, the initial inputs
specified a uniform distribution for Gibbs sampling across a
range of possible values from 50% to 99% for sensitivity or
specificity. All models tested converged to consistent values
within 10,000 iterations, independent of initial values entered.
Ethical considerations.Approval for this study was obtained
from the Institutional Review Boards for Human Studies at
Case Western Reserve University and Emory University.
Approval was also obtained from the Kenya Medical Research
Institute National Ethical Review Committee. Written informed
consent was obtained from adult participants and the parents
or legal guardians of participating children.
RESULTS
Study population.Of 2,525 people canvassed and consented
in three villages in coastal Kenya, 24 people were excluded
because of improper data labeling or missing data, yielding
2,501 participants in the parent study. There were 721 par-
ticipants from Mililani, 1,262 participants from Vuga, and
518 participants from Nganja. Age ranged from 1 to 90 years,
with a median of 17 years of age and an interquartile range
of 14 years old. Based on initial screening (urine filtration of a
single urine and rapid diagnostic card test [RDT] card for
circulating filarial antigen), study villages showed some varia-
tion of prevalence of filariasis and schistosomiasis: Nganja
with 41.1% S. haematobium infection and 9.5% filaria infec-
tion, Vuga with 19.5% Schistosoma and 15.2% filaria, and
Mililani with 43.7% Schistosoma and 13.0% filaria. Table 1
summarizes the baseline characteristics of the total study pop-
ulation as well as the subset of subjects who had triple testing
(MFI, ELISA, and egg count or RDT) done. The prevalence
of the different parasitic infections tested is also described.
There were no apparent differences in the sex and age distri-
bution of the subset compared with the overall group. Further-
more, there did not seem to be an overrepresentation of one
age group over another age group (N = 1,051 ages 0–15 years,
N = 691 ages 16–30 years, andN = 758 over 30 years). In terms
of the village representation in the triple test subset (not
shown), the subjects sampled were distributed evenly among
the three study villages.
Multiplex assay performance versus ELISA and standard
urine filtration or filaria RDT. Antiparasite IgG4 values were
determined for all subjects using the multiplex bead assay.
After completion of this testing, the results of the bead assay
were further compared with ELISA results among a selected
subsample of 111 subjects. Tables 2 and 3 summarize the
positive and negative scoring of the three individual tests
(MFI, ELISA, and filtration or card test) for each parasite
for 111 persons in the test comparison group. Table 4 shows
the IgG4 positivity rates by MFI broken down by age in those
participants who were positive for schistosomiasis and filariasis
by traditional methods (egg count andMDT card, respectively).
For Schistosoma testing, this rate was relatively uniform across
age groups. For IgG4 to BMA, this rate of IgG4 positivity
seemed to increase with age in RDT-positive individuals.
Overall, for Schistosoma diagnosis, 35 of 111 (32%) indi-
viduals in the test group were egg-positive, 51 of 111 (46%)
individuals were anti-SWAP IgG4 ELISA-positive, and 76 of
111 (68%) individuals were anti-SWAP multiplex bead assay-
positive (Table 2). There was strong concordance for positive
ELISA and SWAP multiplex bead assay results; among
Table 1
Study demography and infection prevalence: subset that had ELISA testing versus all study participants
ELISA subset Study group
Total Male Female P value Total Male Female P value
Count 111 53 (47.7) 58 (52.3) 2,501 1,137 (45.5) 1,364 (54.5)
Mean age (years) 30.85 30.30 31.34 0.786 25.19 23.78 26.38 0.000
Schistosome positivity by urine egg count 31.5% 34.0% 29.3% 0.534 30.9% 32.7% 29.5% 0.085
Anti-SWAP IgG4 positivity by assay 68.5% 73.6% 63.8% 0.379 64.1% 67.5% 61.1% 0.001
Anti-SWAP IgG4 positivity by ELISA 46.8% 45.3% 48.3% 0.744
Filariasis positivity by circulating antigen card 16.2% 9.4% 22.4% 0.014 13.4% 14.4% 12.5% 0.240
Anti-BMA IgG4 positivity by assay 67.6% 71.7% 63.8% 0.475 30.4% 32.7% 28.4% 0.020
Anti-BMA IgG4 positivity by ELISA 42.3% 37.7% 46.6% 0.307
Malaria positivity by card 7.2% 7.5% 6.9% 0.868 8.0% 9.0% 7.1% 0.081
Hookworm egg positivity 33.3% 28.3% 37.9% 0.213 23.3% 26.3% 20.7% 0.001
P values compare the sexes, with P < 0.05 considered significant.
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51 SWAP ELISA-positive subjects, 50 (or 98%) subjects were
also bead assay-positive. However, 26 of 60 ELISA-negative
subjects (43%) were bead assay-positive. Among those sub-
jects with positive urine egg counts, 27 of 35 (77%) subjects
were bead assay-positive, whereas 24 of 35 (69%) subjects
were ELISA-positive. Among subjects who were positive by
urine egg count, any ELISA positivity was always matched by
a positive bead assay result. In the study cohort, the SWAP
multiplex assay had a negative predictive value of 77% for
egg positivity compared with an 82% negative predictive
value of the SWAP ELISA. In comparing each assay’s quan-
titative detection of anti-SWAP IgG4, our scatterplot of the
results of traditional ELISA to fluorescence detection in the
new multiplex assay (Figure 1) indicated a strong linear cor-
relation between the results of the two anti-SWAP IgG4
assays (R2 = 0.644, P < 0.01).
For filarial diagnosis, 18 of 111 (16%) individuals in the test
comparison group subjects were RDT-positive for circulating
adult filarial antigen, 47 of 111 (42%) individuals were anti-
BMA IgG4 ELISA-positive, and 75 of 111 (68%) individuals
were anti-BMA multiplex bead assay-positive. Concordance
between ELISA and bead assay was almost as good for
BMA as SWAP—44 of 47 (94%) ELISA positives were
bead-positive, but 31 of 75 (41%) bead positives were
ELISA-negative. Among RDT card-positive subjects, 16 of
18 (89%) subjects were anti-BMA IgG4 multiplex bead
assay-positive, whereas 12 of 18 (67%) subjects were ELISA-
positive. Correlation between anti-BMA IgG4 fluorescence
on bead assay and the BMA ELISA results was significant
but much less strong (R2 = 0.11, P < 0.01) (Figure 2) than for
the anti-SWAP assays.
Absent a true gold standard for laboratory diagnosing of
these helminth infections (i.e., near-perfect sensitivity and
specificity), we used Bayesian latent class analyses for each
infection to help determine the most likely diagnostic perfor-
mance of each individual test for either infection, taking none
of them as a gold standard (Figure 3). Results are shown in
Tables 5 and 6. For both pathogens (S. haematobium and
W. bancrofti), the bead assay was estimated to have greater
sensitivity but less specificity for detection of antiparasite
IgG4 than ELISA. By extension, sensitivity for detection of
the presence of infection (as represented by the latent class
of true infection in latent class analysis models) was better
for the bead assay than ELISA or the reference diagnostic
(i.e., egg filtration for S. haematobium or circulating antigen
detection forW. bancrofti). As is typical for many diagnostics,
increased sensitivity of the bead assay was offset by a decreased
specificity in detection of antiparasite IgG4 or the infection
state, which was estimated in the latent class analysis.
DISCUSSION
For epidemiological studies of parasitism, there is a clear
need for better diagnostic tools to supplement our traditional
parasitological techniques. It is particularly true when it comes
to the chronic infections of schistosomiasis and filariasis. In
our study, both the SWAP and BMA components of the
multiplex bead assay performed well (compared with tradi-
tional ELISAs) in the detection of circulating antiparasite
IgG4, which is taken to be a marker of current or recent infec-
tion.22–24 Increased levels of anti-BMA IgG4 levels have been
correlated with higher levels of circulating microfilaria,31 and
there is evidence that IgG4 does not cross-react with several
other parasitic infections (protozoan and helminths) that are
often coendemic withWuchereria.31 Likewise, antischistosome
IgG4 levels have been correlated with infection intensity and
seem to peak early in infection.24,28,44,45 Whereas studies have
shown lower IgG4 levels in lighter infections, the correlation
between IgG4 positivity and infection status is high (with
greater than 90–95% positivity in infected subjects), making
it a useful marker for current infection.26,39,40,46 Treatment
effects on antischistosome IgG4 have been varied across stud-
ies and can be difficult to interpret given the possibility of
reinfection, differences in methodology, and the ideal time
post-treatment to test.45 Grogan and others28,47 showed a per-
sistence of IgG4 levels against Schistosoma adult worm anti-
gens in both adults and children 5 weeks and 2 years after
treatment, whereas IgG4 levels against egg antigens declined
in all groups at these intervals post-treatment.28,47 Other stud-
ies have supported the decline in IgG4 levels against egg
antigens.26 Several studies have also shown a decrease in
IgG4 levels against adult worm antigens months after treat-
ment, despite the fact that other studies did not.24,27,48 Over-
all, the data seem to support the use of IgG4 levels against
Schistosoma antigens as representative of active, untreated
infection, regardless of subject age, as long as there has been
an ~6- to 12-month window since treatment.
Isotype and subtype antibody profiles after helminth infec-
tion differ with patient age,28 most likely because of an
increase in cumulative exposure to helminth infection over
time.44 IgG4 has been found to be correlated with infection
intensity (as mentioned above). Therefore, it is likely to peak
in the age groups in which infection is most common. Favor-
ing the hypothesis of current exposure-driven generation of
IgG4 levels, Naus and others25 did not find an independent
Table 3
Overall summary ofW. bancrofti diagnostic test results in 111 subjects
included in the triple test comparison
Adult antigen
RDT
ELISA for anti-BMA
IgG4
Bead assay for anti-BMA
IgG4
Number in
group
Positive Positive Positive 12
Positive Positive Negative 0
Positive Negative Positive 4
Positive Negative Negative 2
Negative Positive Positive 32
Negative Positive Negative 3
Negative Negative Positive 27
Negative Negative Negative 31
Table 2
Overall summary of S. haematobium diagnostic test results in
111 subjects included in the triple test comparison
Egg
filtration
ELISA for anti-SWAP
IgG4
Bead assay for anti-SWAP
IgG4
Number in
group
Positive Positive Positive 24
Positive Positive Negative 0
Positive Negative Positive 3
Positive Negative Negative 8
Negative Positive Positive 26
Negative Positive Negative 1
Negative Negative Positive 23
Negative Negative Negative 26
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correlation between age and IgG4 levels in an immigrant
population that was exposed to S. mansoni for the first time.
Again, current infection intensity was related to IgG4 level. In
summary, although the level of antiparasite IgG4 tends to
peak in younger age groups, it is also found to be elevated in
active Schistosoma infections among adults.40,48 In our evalu-
ation, although our sampling strategy and small sample size of
the triple test group did not allow for a breakdown of the test
characteristic analysis by age, it does not seem that IgG4
positivity differed greatly depending on age in those partici-
pants positive for S. haematobium infection by egg counting
(Table 4). Furthermore, age distribution was fairly uniform
across both the ELISA subset and the group as a whole.
Therefore, it does not seem that age had an appreciable influ-
ence on the results and use of IgG4 as a marker for active/
recent infections for schistosomiasis. However, the rate of
IgG4 positivity did seem to go up with age (Table 4) in those
individuals positive for filaria by RDT; however, this group
was overall small, and therefore, it is difficult to make a con-
clusion from these age-stratified values.
Although cross-reactivity between schistosome species and
other helminths has been documented, anti-SWAP has been
found to be parasite-specific in standard assays.22,24,25,44
To further reduce cross-reactivity, we calibrated our assays
using control sera from an area endemic to multiple
helminthes but without schistosomiasis and filariasis to define
the cutoff values.
MFI fluorescence correlated with ELISA optical density,
and because the two bead assays could be run concurrently
with much smaller volumes of patient serum, the MFI seems
to offer an attractive alternative to ELISA for screening large
populations, especially if infection prevalence declines under
the pressure of mass treatment campaigns. Within the limits
of our small pilot study patient sample, the SWAP and BMA
MFI assays yielded greater sensitivity compared with the
corresponding ELISAs, albeit with a decrease in specificity.
Latent class analysis was used for estimation of test perfor-
mance values because of the known insensitivity of standard
testing for active infection.3,49,50 The standard egg filtration
test performed on a single daily urine is estimated to miss up
to 40% of infections detected by more intensive sampling
over 10 consecutive days.49 Similarly, the rapid diagnostic
card for filarial infection detects adult worm antigen but may
not reflect the status of microfilaremia or immune activation
related to more clinically active filariasis.50 The lower sensi-
tivity of anti-BMA ELISA could be caused by several factors:
early stage infection with a delayed immune response, low-
level infection that does not elicit a strong IgG4 immune
response, or technical limitations of the assay. The villages
surveyed in the present study underwent lymphatic filariasis
treatment in the 2 years preceding initiation of the survey.
Subjects may have had circulation of adult filarial worm anti-
gens (as detected by the card tests) but reduced IgG4 because
of markedly reduced microfilaremia. Thus, additional test
evaluations will be needed to define the MFI performance in
detection of low-level or occult infections. Furthermore,
because this pilot study did not have the numbers to stratify
by age or sex, these findings will need to be validated in
larger-scale studies.
The lower specificity of the multiplex assay for both SWAP
and BMA may have been an artifact of the lower sensitivities
of the ELISA tests, because the use of the northern Kenyan
Figure 1. Relationship between SWAP IgG4 multiplex assay
fluorescence and SWAP IgG4 ELISA optical density.
Figure 2. Relationship between BMA IgG4 multiplex assay
fluorescence and BMA IgG4 ELISA optical density.
Table 4
Total age distribution and MFI assay positivity by age group among RDT-positive and S. haematobium egg-positive subjects
Age groups 0–15 years (total N = 1,051) 16–30 years (total N = 691) > 30 years (total N = 758)
Anti-BMA IgG4 MFI-positive among RDT card-positive 22% (N = 28) 36% (N = 30) 58% (N = 72)
Anti-SWAP IgG4 MFI-positive among S. haematobium egg-positive 81% (N = 351) 89% (N = 217) 91% (N = 87)
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controls (where neither schistosomiasis nor filariasis is
endemic) to determine cutoffs should have decreased the
cross-reactivity of the assay. Although lower specificity of
IgG4 for lymphatic filariasis compared with PCR has been
attributed to likely cross-reactivity, the fact that there are no
other major filarial parasites endemic to this area makes
cross-reactivity less of an issue in our study.51 Lastly, the
subset that had the ELISA testing was similar to the overall
group with respect to age (mean age was 30.85 years for the
ELISA subgroup and 25.19 years overall) and sex (31.34%
female for the ELISA subgroup and 26.38% female overall),
which is evidenced in Table 1. Therefore, the makeup of the
subpopulation does not seem to have shaped the observed
performance characteristics of the tests. Furthermore, although
village makeup of the ELISA subset versus the overall group
was slightly different (with Vuga having more participants in
the overall group and the ELISA group spread evenly over
the villages), it is unlikely that this difference had an impact
on the performance characteristics of the tests.
One of the potential advantages of the MFI assay is that a
very small amount of serum or plasma can be simultaneously
tested for antibodies to several parasite infections, thus maxi-
mizing efficiency and minimizing the participants’ risk from
larger blood draws. There are limitations, however, on the use
of MFI for antiparasite antibody testing. In our hands, beads
prepared using hookworm excretory/secretory antigens
proved unable to detect antihookworm IgG4, although the
antigens performed well when detecting antihookworm total
IgG and when used in standard ELISAs. It is possible that
conformational changes created by covalent linkage of the
antigen to the beads may have masked its immune epitopes.
However, we believe that, for many other pathogens, conju-
gated antigen–beads could be added to our multiplex assay
for linked serologic diagnosis. Because MFI can be used for
measuring levels of other biomarkers, such as cytokines and
iron metabolism markers, the possibilities for concurrently
assessing the morbidity of parasitic coinfections with one
small sample of blood are numerous.
Future studies with MFI should examine the use of soluble
egg antigen preparation for detection of IgG4 associated with
S. haematobium infection, because it has been more consis-
tently associated with declines in antiparasite IgG4 levels
post-treatment.28,47 There are other promising tools for highly
sensitive diagnosis of helminth infections, such as the recently
reported urine DNA test for S. haematobium.52,53 However,
these tests are single-species tests at present, and therefore,
the benefits of multiplex MFI techniques in epidemiologic
studies remain. Furthermore, because there is not yet a gold
standard for diagnosis of Schistosoma or lymphatic filariasis
infection, improvements in existing means of serologic testing
will expand the epidemiological tools for measuring burden of
disease in vulnerable populations.
In summary, where concurrent transmission of parasite
infections still occurs, sensitive and efficient detection will
be required. Although serological testing with IgG4 does
have limitations (as outlined above), novel multiplex serolog-
ical assays could prove to be useful epidemiologic tools for
effective mapping and surveillance. The current MFI assay
performs in a fashion similar to traditional ELISAs for detec-
tion of antiparasite IgG4, but it is able to obtain the informa-
tion more efficiently (i.e., simultaneously with minimal
amounts of serum). Our future work will focus on optimizing
Figure 3. Two-class model for estimation of the diagnostic performance of the novel antiparasite IgG4 multiplex assays compared with
standard parasitology and classical ELISA technique.
Table 5
Estimated sensitivity and specificity for S. haematobium infection by latent class analysis of three laboratory tests
Diagnostic test
Sensitivity for anti-SWAP
IgG4 detection*
Specificity for anti-SWAP
IgG4 detection
Sensitivity for S. haematobium
infection†
Specificity for S. haematobium
infection
Median estimate (%) 95% CI‡ Median estimate (%) 95% CI‡ Median estimate (%) 95% CI‡ Median estimate (%) 95% CI‡
Egg filtration – – – – 62 38–95 98 95–99
ELISA 89 68–99 95 84–99.7 65 47–81 72 55–93
Multiplex bead assay 97 89–99.8 61 46–83 81 68–90 45 31–65
Values are based on combined results from (1) egg detection in subject’s urine, (2) anti-SWAP IgG4 ELISA, and (3) anti-SWAP IgG4 fluorescent bead assay for 111 study participants in
Kwale County, Kenya.
*True prevalence of anti-SWAP IgG4 in the study subsample was estimated by the Bayesian Latent Class model to be 49.8%.
†True prevalence of S. haematobium infection in the study subsample was estimated to be 49.5%.
‡95% credible interval.
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the discrimination of the MFI assay and comparing the map-
ping of parasitic disease distribution in coastal Kenya by
standard testing and this novel multiplex assay.
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